Decreased Gut Microbiome Tryptophan Metabolism and Serotonergic Signaling in Patients With Persistent Mental Health and Gastrointestinal Symptoms After COVID-19

An estimated 15%–29% of patients report new gastrointestinal (GI) symptoms after coronavirus-19 disease (COVID-19) while 4%–31% report new depressive symptoms. These symptoms may be secondary to gut microbiome tryptophan metabolism and 5-hydroxytryptamine (5-HT)-based signaling. METHODS: This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackett, John W., Sun, Yiwei, Purpura, Lawrence, Margolis, Kara Gross, Elkind, Mitchell S.V., O'Byrne, Sheila, Wainberg, Milton, Abrams, Julian A., Wang, Harris H., Chang, Lin, Freedberg, Daniel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624499/
https://www.ncbi.nlm.nih.gov/pubmed/36049050
http://dx.doi.org/10.14309/ctg.0000000000000524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624499/
https://www.ncbi.nlm.nih.gov/pubmed/36049050
http://dx.doi.org/10.14309/ctg.0000000000000524

Ejemplares similares